Digital ECG maker AliveCor is teaming up with Chinese wearable company Huami Corporation on a new effort to combine the pair’s technology into medical-grade wearables.
The end goal is to have an ECG-enabled wearable with various heart features on the market by 2020.
"AliveCor's agreement with Huami achieves our corporate goal of delivering AliveCor's AI-driven subscription services and...
Update: This story has been updated to include additional comments from AliveCor.
Mobile ECG maker AliveCor has ended sales of KardiaBand, its FDA-cleared ECG wristband designed for use with Apple Watches, a representative of the company confirmed to MobiHealthNews today.
The company appears to have pulled down the device’s purchase page sometime after June 12, according to cached versions of...
Over the weekend AliveCor announced that its technology was validated in two studies. The first found that its KardiaBand, which works as a personal electrocardiogram device, can accurately detect atrial fibrillation (AFib) when used with the Apple Watch. The second study, which was a collaboration with the Mayo Clinic found that its ECG device, when paired with AI, could detect hyperkalemia.
“...
AliveCor has launched (and received FDA clearance for) a new ECG sensor built into an Apple Watch strap, as well as an Apple Watch app on which users can see their ECG in near real-time.
The strap, called KardiaBand, is an upgraded version of a product that launched in Europe last year. But in addition to the band, AliveCor is launching SmartRhythm, a software that continuously measures heart...
This morning, San Francisco-based AliveCor rebranded its AliveCor Mobile ECG device as Kardia Mobile and unveiled a second, upcoming hardware product, an Apple Watch strap that can take electrocardiogram (ECG or EKG) readings, called KardiaBand. The strap is not yet commercially available because it still needs to secure FDA-clearance.
AliveCor also announced new features for the Kardia Mobile...
